(AEVS) Aevis Victoria SA - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0478634105
AEVS: Healthcare, Hospitality, Real Estate, Telemedicine, Ambulance, Radiology, Pharmacy
Aevis Victoria SA is a Swiss-based conglomerate with a diverse portfolio of businesses, primarily focused on the healthcare, hospitality, lifestyle, and infrastructure sectors. The company's operations are organized into distinct segments, including Hospitals, Hospitality, Real Estate, and Others, allowing for a structured approach to managing its various interests. Through these segments, Aevis Victoria SA provides a wide range of services, including telemedicine, ambulance services, and life sciences-related activities, demonstrating its commitment to comprehensive healthcare solutions.
In addition to its core healthcare services, the company also operates a variety of ancillary businesses, such as patient hotels, radiology institutes, pharmacies, and ophthalmology clinics, further expanding its reach within the healthcare sector. Moreover, Aevis Victoria SA offers specialized services like urology centers, health centers, and day clinics, catering to specific medical needs. The company's presence in the lifestyle sector is marked by its operation of golf courses, highlighting its interest in leisure and wellness activities. Other support services, including parking, cleaning, sterilization, and IT-related services, round out the company's portfolio, showcasing its aim to provide integrated solutions.
As a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A., Aevis Victoria SA benefits from its parent company's expertise and resources, potentially enhancing its own capabilities and strategic direction. With its headquarters in Fribourg, Switzerland, the company is well-positioned to serve both local and international markets. Aevis Victoria SA's common stock is listed with the ISIN CH0478634105, and it is classified under the GICS Sub Industry of Health Care Facilities, reflecting its primary focus on healthcare services and infrastructure. The company's web presence can be found at https://www.aevis.com, offering a gateway to its corporate information, services, and initiatives.
Additional Sources for AEVS Stock
AEVS Stock Overview
Market Cap in USD | 1,377m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception |
AEVS Stock Ratings
Growth 5y | 10.1% |
Fundamental | -4.57% |
Dividend | 9.91% |
Rel. Strength Industry | -482 |
Analysts | - |
Fair Price Momentum | 13.00 CHF |
Fair Price DCF | - |
AEVS Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 48.3% |
AEVS Growth Ratios
Growth Correlation 3m | 23.5% |
Growth Correlation 12m | -81.9% |
Growth Correlation 5y | 64.5% |
CAGR 5y | 1.38% |
CAGR/Mean DD 5y | 0.09 |
Sharpe Ratio 12m | -0.58 |
Alpha | -24.76 |
Beta | 0.27 |
Volatility | 59.15% |
Current Volume | 3.5k |
Average Volume 20d | 6.6k |
As of January 22, 2025, the stock is trading at CHF 14.00 with a total of 3,519 shares traded.
Over the past week, the price has changed by +5.15%, over one month by +2.14%, over three months by +2.51% and over the past year by -12.80%.
Neither. Based on ValueRay Fundamental Analyses, Aevis Victoria SA is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -4.57 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AEVS as of January 2025 is 13.00. This means that AEVS is currently overvalued and has a potential downside of -7.14%.
Aevis Victoria SA has no consensus analysts rating.
According to ValueRays Forecast Model, AEVS Aevis Victoria SA will be worth about 14 in January 2026. The stock is currently trading at 14.00. This means that the stock has a potential upside of +0.29%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 15 | 7.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 14 | 0.3% |